Board of Directors

Michel Saucier
Chairman of the Board

Jean-Yves Leblanc
Vice President of the Board

Jean-Marc Proulx
Treasurer of the Board
President and CEO, Génome Québec

Denis Bilodeau
Vice-President, Administration, Génome Québec

Claude C. Bismuth
Consultant, Bismuth Consulting

Ghislain Boudreau
Vice President, Public Affairs, Pfizer Canada

Clarissa Desjardins
Chief Executive Officer, Cepmed

Denis Garceau
Senior Vice-President, Drug Development, Bellus Health

Stanislav Glezer
Vice-President, Medical Affairs, Sanofi-Aventis

Jacques Mizrahi
Head of Clinical Research & Exploratory Development, Metabolic & Vascular Diseases, Hoffman La Roche

Jean-Claude Tardif
Director, MHI Research Centre Pfizer Chair and of the Canadian Institutes of Health Research in Atherosclerosis – Professor of Medicine, Montreal Heart Institute

Brigit Viens
Observer for the Federal government – Senior Program Manager, Networks of Centres of Excellence (NCE)

Marc Zarenda, Scientific Director
Medical Science, AstraZeneca Canada